Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft. - Wikidata - wikimedia - TriplyDB

Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft.

Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft.

http://www.wikidata.org/entity/Q36356414

about

The role of microRNAs in bladder cancer Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical Therapy Long non-coding RNA regulation of epithelial-mesenchymal transition in cancer metastasis A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion.MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder A Functional rs353293 Polymorphism in the Promoter of miR-143/145 Is Associated with a Reduced Risk of Bladder Cancer.Targeting MicroRNAs in Cancer Gene Therapy.MicroRNA Expression Profile Identifies High Grade, Non-Muscle-Invasive Bladder Tumors at Elevated Risk to Progress to an Invasive Phenotype Organ-Specific MicroRNAs (MIR122, 137, and 206) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (PKM) Expression.

P2860

Q26744149-7A2EEB4E-499F-476B-96FB-4BBB9E41AA07 Q26774965-E9864756-D76A-4721-8A7D-73073DE62D5A Q28066271-48B4A32C-7BB1-4108-A850-B51FA17BC5DA Q32183014-79B2372D-452E-4661-9D4F-CE2CB8C874D9 Q33670786-A7351953-5A07-4648-A430-CC879B8587EE Q33779355-9C5F23D2-0AE1-4A29-9CB8-815C94EFCD59 Q33829415-14BC23A4-A02D-4923-A0C3-E97D541B3F40 Q36082815-4B225327-DB5B-49FD-BD33-94D7D1234C33 Q37628264-45705B8C-120C-4889-AD0D-F2D48ED02D49 Q37676257-7F07FC1A-8072-4624-9CFD-8284A6D061EE Q54980243-07B2A8EE-28A4-4722-B23B-B1B276B621B2

P2860

Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft.

http://www.wikidata.org/entity/Q36356414

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Intravesical administration of ...... uman bladder cancer xenograft.

@ast

Intravesical administration of ...... uman bladder cancer xenograft.

@en

type

label

Intravesical administration of ...... uman bladder cancer xenograft.

@ast

Intravesical administration of ...... uman bladder cancer xenograft.

@en

prefLabel

Intravesical administration of ...... uman bladder cancer xenograft.

@ast

Intravesical administration of ...... uman bladder cancer xenograft.

@en

P1433

Q36356414-E0B3CCCB-90B0-4C02-AA71-AE3CDCFB8B61

P1476

Q36356414-E82B863E-1C55-499F-83AA-5B25E4577912

P2093

Q36356414-17F3CF6E-C766-4DD1-B88A-D4465B4D1CDA

Q36356414-1FEB9382-E728-4ECD-90D9-3B64BCB96C7E

Q36356414-27ED9844-67B7-449A-8C06-C42DA2E151D8

Q36356414-31F3384C-5311-4644-9877-F2EDA834EE08

Q36356414-3977C230-71F1-4CC5-AA56-60100D7DE1C6

Q36356414-47CEE480-4971-4C61-B38F-7ED55214C335

Q36356414-67D5CE54-8DEB-452B-BBF4-2F2F2735750F

Q36356414-72515A76-FBA3-4CE3-9EC5-BAB9C35FEB02

Q36356414-86982E6F-8C27-44C1-ADEB-C7D9C088E5CD

Q36356414-8A94F369-C952-4A91-9A1B-EBDCE95C6EDB

P2860

Q36356414-12BA326C-B91E-4B97-8E59-6AE6407F4E98

Q36356414-1FEA50B5-ED24-4739-BA62-269C7DFC6CA1

Q36356414-237F0D71-2CFC-4C95-BD50-C22D80D45900

Q36356414-335F6B1C-12E6-427D-AD80-DD1E238BAD79

Q36356414-4B54A1EE-BFE4-425A-B388-7CCD06AEBDFC

Q36356414-5D3BD832-7964-4998-A6A2-9F534F18AA48

Q36356414-6ABD6D97-8564-4595-BEB7-4C2C3E1784DD

Q36356414-6EC56034-A37A-4DC7-B357-AAE8F869F58F

Q36356414-6ED33B90-A5A8-450D-AE6D-50597F79B6B4

Q36356414-816BD8A2-3BCC-4531-9F57-DB8565FD8CF6

P304

Q36356414-C98BFA4F-9BB1-4657-8E8A-AD2EB7A7DE96

P31

Q36356414-1A960A3D-C9B6-4D08-8349-847203EAB412

P356

Q36356414-42A21771-B8FA-4E87-B9D3-DF64966466DE

P407

Q36356414-2E2DE877-1069-46A8-9E34-1261BD93A4E7

P433

Q36356414-4E6D613C-D11D-4E51-BB85-7A6052F23D88

P478

Q36356414-7C261768-AC10-420E-827E-09EC8F83404E

P50

Q36356414-BD80370C-1568-4E91-A833-D5E5E986DB1E

P577

Q36356414-C285D3B7-14A4-40D7-8282-6D23F4EEDAA5

P698

Q36356414-16DEEAD2-607D-4501-8D20-27D5B756EFB6

P921

Q36356414-2745A005-F468-42EC-97F9-D3493E8FD109

Q36356414-925FB1F5-5490-47D0-9DAB-0DFFBB0201CF

P932

Q36356414-1FCB5DEA-C56E-44EA-85F0-5BC4AB13DAFD

P356

ONCOTARGET.4129

P1433

P1476

Intravesical administration of ...... human bladder cancer xenograft

@en

P2093

Ayako Iwatsuki

http://www.w3.org/2001/XMLSchema#string

Hajime Hirano

http://www.w3.org/2001/XMLSchema#string

Haruhito Azuma

http://www.w3.org/2001/XMLSchema#string

Hayahito Nomi

http://www.w3.org/2001/XMLSchema#string

Hirofumi Uehara

http://www.w3.org/2001/XMLSchema#string

Junko Kouno

http://www.w3.org/2001/XMLSchema#string

Kazumasa Komura

http://www.w3.org/2001/XMLSchema#string

Kenkichi Saito

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Takahara

http://www.w3.org/2001/XMLSchema#string

Koichiro Minami

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of non-coding RNAs embracing microRNA-143/145 cluster

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS).

In vivo imaging reveals PKA regulation of ERK activity during neutrophil recruitment to inflamed intestines.

Role of anti-oncomirs miR-143 and -145 in human colorectal tumors.

Exosome can prevent RNase from degrading microRNA in feces.

MicroRNA-143 and -145 in colon cancer.

1,1-Bis(3'-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth.

Recurrence of high-risk bladder cancer: a population-based analysis.

MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers.

P304

21628-21635

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.4129

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Kohei Taniguchi

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26036261

http://www.w3.org/2001/XMLSchema#string

P921

P932

4673291

http://www.w3.org/2001/XMLSchema#string